Fred Hofmann

Title: Fred Hofmann: Innovator in Clostridial Neurotoxins

Introduction

Fred Hofmann is a distinguished inventor based in Potsdam, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant clostridial neurotoxins. With a total of 12 patents to his name, Hofmann's work has the potential to impact various medical applications.

Latest Patents

Hofmann's latest patents include groundbreaking inventions related to recombinant botulinum toxins. One of his notable inventions is a recombinant botulinum toxin with an increased duration of effect. This invention focuses on novel recombinant clostridial neurotoxins that exhibit an extended duration of effect without a delayed onset. The methods for manufacturing these neurotoxins involve inserting a nucleic acid sequence coding for a specific domain into a parental clostridial neurotoxin. Additionally, he has developed recombinant clostridial neurotoxins with increased duration of effect, which also utilize a random coil domain in their structure.

Career Highlights

Throughout his career, Hofmann has worked with reputable companies, including Merz Pharma GmbH & Co. KGaA. His expertise in biotechnology and neurotoxin research has positioned him as a key figure in the industry.

Collaborations

Hofmann has collaborated with notable professionals in his field, including Jürgen Frevert and Manuela López De La Paz. These collaborations have further enriched his research and development efforts.

Conclusion

Fred Hofmann's innovative work in the field of recombinant clostridial neurotoxins showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic options and enhancing our understanding of neurotoxin applications.